Histone Methyltransferase G9a Promotes the Development of Renal Cancer Through Epigenetic Silencing of Tumor Suppressor Gene SPINK5

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2021 Aug 2

PMID 34336110

Citations 15

Authors

Ren-Gui Li

Huan Deng

Xiu-Heng Liu

Zhi-Yuan Chen

Shan-Shan Wan

Lei Wang

Affiliations

Soon will be listed here.

Abstract

Background: Renal cell carcinoma (RCC) accounts for approximately 2-3% of malignant tumors in adults, while clear cell renal cell carcinoma accounts for 70-85% of kidney cancer cases, with an increasing incidence worldwide. G9a is the second histone methyltransferase found in mammals, catalyzing lysine and histone methylation. It regulates gene transcription by catalyzing histone methylation and interacting with transcription factors to alter the tightness of histone-DNA binding. The main purpose of this study is to explore the role and mechanism of G9a in renal cell carcinoma.

Methods: Firstly, we investigated the expression of G9a in 80 clinical tissues and four cell lines. Then, we explored the effect of G9a-specific inhibitor UNC0638 on proliferation, apoptosis, migration, and invasion of two renal cancer cell lines (786-O, SN12C). In order to study the specific mechanism, G9a knocking down renal cancer cell line was constructed by lentivirus. Finally, we identified the downstream target genes of G9a using ChIP experiments and rescue experiments.

Results: The results showed that the specific G9a inhibitor UNC0638 significantly inhibited the proliferation, migration, and invasion of kidney cancer and ; similar results were obtained after knocking down G9a. Meanwhile, we demonstrated that SPINK5 was one of the downstream target genes of G9a through ChIP assay and proved that G9a downregulate the expression of SPINK5 by methylation of H3K9me2. Therefore, targeting G9a might be a new approach to the treatment of kidney cancer.

Conclusion: G9a was upregulated in renal cancer and could promote the development of renal cancer and . Furthermore, we identified SPINK5 as one of the downstream target genes of G9a. Therefore, targeting G9a might be a new treatment for kidney cancer.

Citing Articles

Therapeutic targeting potential of the protein lysine and arginine methyltransferases to reverse cancer chemoresistance.

Micallef I, Fenech K, Baron B Front Mol Biosci. 2024; 11:1455415.

PMID: 39703687 PMC: 11656028. DOI: 10.3389/fmolb.2024.1455415.

GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms.

Silva-Carvalho A, Filiu-Braga L, Bogea G, de Assis A, Pittella-Silva F, Saldanha-Araujo F Cancer Cell Int. 2024; 24(1):243.

PMID: 38997742 PMC: 11249034. DOI: 10.1186/s12935-024-03441-y.

The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update.

Zhou H, Gui J, Zhu L, Mi Y Onco Targets Ther. 2024; 17:449-462.

PMID: 38832355 PMC: 11146345. DOI: 10.2147/OTT.S451108.

Molecular and functional anticancer effects of GLP/G9a inhibition by UNC0646 in MeWo melanoma cells.

Filiu-Braga L, Silva-Carvalho A, Sousa M, Carvalho J, Saldanha-Araujo F Heliyon. 2024; 10(5):e27085.

PMID: 38434406 PMC: 10907798. DOI: 10.1016/j.heliyon.2024.e27085.

High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach.

Hsu C, Chang K, Chuang T, Chu M, Lin P, Liu H Cancers (Basel). 2023; 15(16).

PMID: 37627178 PMC: 10452841. DOI: 10.3390/cancers15164150.

References

Liu X, Zhou L, Hu J, Liu L, Wan H, Zhang X . UNC0638, a G9a inhibitor, suppresses epithelial‑mesenchymal transition‑mediated cellular migration and invasion in triple negative breast cancer. Mol Med Rep. 2017; 17(2):2239-2244. PMC: 5783465. DOI: 10.3892/mmr.2017.8190. View

Zhang T, Termanis A, Ozkan B, Bao X, Culley J, de Lima Alves F . G9a/GLP Complex Maintains Imprinted DNA Methylation in Embryonic Stem Cells. Cell Rep. 2016; 15(1):77-85. PMC: 4826439. DOI: 10.1016/j.celrep.2016.03.007. View

Zhang J, Wang Y, Shen Y, He P, Ding J, Chen Y . G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of . Theranostics. 2018; 8(10):2884-2895. PMC: 5957015. DOI: 10.7150/thno.23824. View

Ida S, Ozaki N, Araki K, Hirashima K, Zaitsu Y, Taki K . SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer. Mol Cancer Res. 2015; 13(7):1130-8. DOI: 10.1158/1541-7786.MCR-14-0581. View

Vedadi M, Barsyte-Lovejoy D, Liu F, Rival-Gervier S, Allali-Hassani A, Labrie V . A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol. 2011; 7(8):566-74. PMC: 3184254. DOI: 10.1038/nchembio.599. View

Dong C, Wu Y, Yao J, Wang Y, Yu Y, Rychahou P . G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest. 2012; 122(4):1469-86. PMC: 3314447. DOI: 10.1172/JCI57349. View

Rao V, Ow J, Shankar S, Bharathy N, Manikandan J, Wang Y . G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation. Nucleic Acids Res. 2016; 44(17):8129-43. PMC: 5041453. DOI: 10.1093/nar/gkw483. View

Ding J, Li T, Wang X, Zhao E, Choi J, Yang L . The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab. 2013; 18(6):896-907. PMC: 3878056. DOI: 10.1016/j.cmet.2013.11.004. View

Pei J, Deng J, Ye Z, Wang J, Gou H, Liu W . Absence of autophagy promotes apoptosis by modulating the ROS-dependent RLR signaling pathway in classical swine fever virus-infected cells. Autophagy. 2016; 12(10):1738-1758. PMC: 5079672. DOI: 10.1080/15548627.2016.1196318. View

10.

Mayr C, Helm K, Jakab M, Ritter M, Shrestha R, Makaju R . The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer. Hum Pathol. 2017; 72:117-126. DOI: 10.1016/j.humpath.2017.11.003. View

11.

Wang Q, Lv Q, Bian H, Yang L, Guo K, Ye S . A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer. Cancer Med. 2019; 8(5):2360-2371. PMC: 6537088. DOI: 10.1002/cam4.2078. View

12.

Staunton J, Slonim D, Coller H, Tamayo P, Angelo M, Park J . Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A. 2001; 98(19):10787-92. PMC: 58553. DOI: 10.1073/pnas.191368598. View

13.

Wei L, Chiu D, Tsang F, Law C, Cheng C, Au S . Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J Hepatol. 2017; 67(4):758-769. DOI: 10.1016/j.jhep.2017.05.015. View

14.

Deng H, Ma J, Liu Y, He P, Dong W . Combining α-Hederin with cisplatin increases the apoptosis of gastric cancer in vivo and in vitro via mitochondrial related apoptosis pathway. Biomed Pharmacother. 2019; 120:109477. DOI: 10.1016/j.biopha.2019.109477. View

15.

Cho H, Kelly J, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M . Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia. 2011; 13(8):676-84. PMC: 3156658. DOI: 10.1593/neo.11512. View

16.

Shankar S, Bahirvani A, Rao V, Bharathy N, Ow J, Taneja R . G9a, a multipotent regulator of gene expression. Epigenetics. 2012; 8(1):16-22. PMC: 3549875. DOI: 10.4161/epi.23331. View

17.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

18.

Artal-Martinez de Narvajas A, Gomez T, Zhang J, Mann A, Taoda Y, Gorman J . Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol. 2013; 33(20):3983-93. PMC: 3811684. DOI: 10.1128/MCB.00813-13. View

19.

Chen M, Hua K, Kao H, Chi C, Wei L, Johansson G . H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 2010; 70(20):7830-40. DOI: 10.1158/0008-5472.CAN-10-0833. View

20.

Zhang X, Peng D, Xi Y, Yuan C, Sagum C, Klein B . G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression. Nat Commun. 2016; 7:10810. PMC: 4792926. DOI: 10.1038/ncomms10810. View